BRCA Carriers Slicing Breast Cancer Odds: Does Surgery Really Lead to Longevity Leaps? Text: @OncoAlert…

EMBER-3 Trial: Pioneering Results in Advanced Breast Cancer TreatmentThe results of the Phase 3 EMBER-3…

Introduction:Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as…

In the rapidly evolving field of cancer treatment, the application of comprehensive genomic profiling (CGP)…

We recognize that That combination also made them immunogenic. And so there was always recognition. Over time we came to appreciate that when you see the immune system in there where there’s immune lymphocytes in the tumor, those tumors, those patients seem to do better even in the absence of drug therapy and with drug therapy they do better still.